How the diabetic eye loses vision
- PMID: 17992608
- DOI: 10.1007/s12020-007-0040-9
How the diabetic eye loses vision
Abstract
The objective is to review the most common causes of vision loss in patients with diabetes with the goal of better managing patients with diabetic eye disease. In this review, the causes of vision loss, and the clinical evaluation and management of diabetic retinopathy (DR) and diabetic macular edema (DME) are outlined. Patients with diabetes mellitus have an increased risk of vision loss and blindness. In patients with diabetes, the primary mechanism responsible for vision loss is centrally involved DME or clinically significant macular edema (CSME), defined as vascular leakage resulting in fluid accumulation that affects the center of the macula. DR and DME are thought to result from the effects of excessive blood glucose on the vessels that produces microvascular damage. The progression of DR can be slowed by intensive glycemic and blood pressure control. Severe visual loss from proliferative DR and moderate visual loss from DME can be reduced by laser photocoagulation. DR and DME are diagnosed on dilated retinal examination and confirmed with diagnostic testing. Many experts and associations recommend that patients with diabetes have an yearly, thorough, dilated eye exam. This manuscript describes the case history of a patient with diabetes and vision loss.
Similar articles
-
Algorithms for Diagnosis of Diabetic Retinopathy and Diabetic Macula Edema- A Review.Adv Exp Med Biol. 2021;1307:357-373. doi: 10.1007/5584_2020_499. Adv Exp Med Biol. 2021. PMID: 32166636 Review.
-
Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.Clin Exp Optom. 2012 May;95(3):362-70. doi: 10.1111/j.1444-0938.2012.00742.x. Epub 2012 Apr 27. Clin Exp Optom. 2012. PMID: 22537275
-
The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):677-84. doi: 10.1167/iovs.11-8992. Invest Ophthalmol Vis Sci. 2012. PMID: 22205611
-
Optimizing treatment for diabetic macular edema during cataract surgery.Front Endocrinol (Lausanne). 2023 Jan 25;14:1106706. doi: 10.3389/fendo.2023.1106706. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36761187 Free PMC article. Review.
-
Vision Loss in Older Adults.Am Fam Physician. 2016 Aug 1;94(3):219-26. Am Fam Physician. 2016. PMID: 27479624 Review.
Cited by
-
Performance of a new reusable insulin pen.Diabetes Technol Ther. 2011 Mar;13(3):373-9. doi: 10.1089/dia.2010.0174. Epub 2011 Feb 3. Diabetes Technol Ther. 2011. PMID: 21291331 Free PMC article.
-
Prevalence of vision impairment among patients with diabetes mellitus in sub-Saharan Africa: A systematic review and meta-analysis.PLoS One. 2025 Jun 24;20(6):e0326176. doi: 10.1371/journal.pone.0326176. eCollection 2025. PLoS One. 2025. PMID: 40554578 Free PMC article.
-
PPARgamma Agonists: Potential as Therapeutics for Neovascular Retinopathies.PPAR Res. 2008;2008:164273. doi: 10.1155/2008/164273. PPAR Res. 2008. PMID: 18509499 Free PMC article.
-
Chemokines in diabetic eye disease.Diabetol Metab Syndr. 2024 May 24;16(1):115. doi: 10.1186/s13098-024-01297-w. Diabetol Metab Syndr. 2024. PMID: 38790059 Free PMC article.
-
Laser photocoagulation for proliferative diabetic retinopathy.Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD011234. doi: 10.1002/14651858.CD011234.pub2. Cochrane Database Syst Rev. 2014. PMID: 25420029 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical